Amount$20M
AnnouncedDec 30, 2009
SectorOncology, Immunology, Life Sciences
Mixed
A mixed round — some signals are off the norm.
Syndicate size
Single investor — limited external validation.
Insider conviction
All-new money — no prior investors re-upped.
Investor track record
Mostly newer or unproven managers.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Oncology, Immunology, Life Sciences (5)
Round size in sector80th pct
$12Mthis round: $20M$20M
